UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported) October 17, 2019
SUNLINK HEALTH SYSTEMS, INC.
(Exact Name Of Registrant As Specified In Charter)
|
|
|
|
|
Ohio |
|
1-12607 |
|
31-0621189 |
(State or other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|||
900 Circle 75 Parkway, Suite 1120, Atlanta, Georgia |
|
30339 |
||
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code (770) 933-7000
(Former Name Or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A-2. below:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each Class |
Trading Symbol |
Name of each Exchange on which registered |
Common Shares without par value Preferred Share Purchase Rights |
SSY - |
NYSE American, LLC - |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On October 17, 2019, SunLink Health Systems, Inc. announced that it has filed with the Securities and Exchange Commission a Form 13e-3 relating to the share repurchase plan approved by its Board. The share repurchase program authorizes the Company to expend up to $750,000 to purchase shares of its common stock in the open market. A notice is currently being mailed to all shareholders describing the plan, and the company will commence purchases, at its discretion, under the plan no sooner than November 14, 2019, 30 days after the mailing of the notice.
Item 9.01 Financial Statements and Exhibits.
d. Exhibits. The following exhibit is filed with this report:
Exhibit 99.1 – SunLink Health Systems, Inc. Press Release dated October 17, 2019.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
SUNLINK HEALTH SYSTEMS, INC. |
||
|
|
|
|
|
|
By: |
|
/s/ Mark J. Stockslager |
Name: |
|
Mark J. Stockslager |
Title: |
|
Chief Financial Officer |
Dated: October 17, 2019
3